News | News By Subject | News by Disease News By Date | Search News

Alzheimer's Disease News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
Anavex (AVXL)’s Alzheimer’s Drug a Possible Game Changer After Patients Reported Remarkable Positive Response     4/28/2016
A Day After The Pfizer (PFE)-Allergan (AGN) Deal Dies, Allergan Inks Potential $3.3 Billion Alzheimer’s Deal with Heptares     4/11/2016
AstraZeneca PLC (AZN), Eli Lilly (LLY) Alzheimer's Drug Enters Final Testing Stage, Astra Earns $100 Million     4/8/2016
TauRx Pharma Co-Founder's 30-Year Alzheimer's Quest May Bear Fruit in July     3/21/2016
Eli Lilly (LLY) Dropped After Primary Goal of Alzheimer's Study Was Changed     3/18/2016
Alzheon Wants Another Shot at Alzheimer's, Presents Data for Tweaked Phase III Studies on Once-Rejected Drug Tramiprosate     3/11/2016
As Pfizer (PFE) Kills Alzheimer's Trial, Axovant (AXON) Stock Plunges     2/3/2016
Denali, Helmed by Former Genentech (RHHBY) Execs, Takes Space in South San Francisco Site     1/20/2016
Pint-Sized Anavex (AVXL) May Soon Have the Data to Prove Biogen (BIIB) and Eli Lilly (LLY)'s Alzheimer's Approach is All Wrong     12/10/2015
Anavex (AVXL) May Have Just Become a Target for Biogen (BIIB) and Eli Lilly (LLY)     12/2/2015
Transition Therapeutics (TTH.TO)'s Alzheimer's Drug Effective in ELND005 Phase II/III Study     10/15/2015
TauRx Completes $135 Million Funding Round to Support Phase III Trials for Key Products     10/8/2015
30-Year-Old Hedge-Fund Whiz Kid’s Axovant (AXON) Starts Alzheimer’s Phase III Trial     10/7/2015
Nestle SA Advances Further into Medicine with Planned Alzheimer's Test     9/23/2015
FORUM Pharma Halts Clinical Trials for Alzheimer’s and Schizophrenia Drug     9/17/2015

News from Around the Web
Bad Sense Of Direction May Be An Early Sign Of Alzheimer’s, Washington University in St. Louis Study Suggests     4/27/2016
Does A Person's Education Level Reduce The Risk Of Alzheimer's? Boston University Study     4/25/2016
Maple Syrup Protects Neurons And Nurtures Young Minds, University Of Montreal Hospital Research Centre Study     4/14/2016
Why People With Alzheimer's Stop Recognizing Their Loved Ones, Université de Montréal Study     4/11/2016
People With Low Body Temperature Have Worst Alzheimer's Symptoms, Universite Laval Study     4/8/2016
How To Transform Your Coffee Into A Wonder Drug     3/23/2016
Implantable Capsule Shows Promise For Alzheimer's Prevention, EPFL Study     3/21/2016
What Science Tells Us Can Affect Our Alzheimer's Disease Risk     3/18/2016
"Lost" Memories In Alzheimer Patients Can Be Found, MIT Study     3/18/2016
Women With Alzheimer's May Keep Verbal Skills Longer Than Men, Albert Einstein College of Medicine Study     3/17/2016
Natural Omega-3 Fatty Acids May Help In Preventing Alzheimer's Disease, Charité -- Universitätsmedizin Berlin Study     3/16/2016
Blueberries Could Help Fight Alzheimer's, University of Cincinnati Study     3/14/2016
Could A Pure Maple Syrup Extract Help Fight Alzheimer's? University of Rhode Island Study     3/14/2016
Gum Disease Linked To Alzheimer's, King's College London Study     3/11/2016
Burning More Calories May Cut Your Alzheimer’s Risk, University of Pittsburgh Study     3/11/2016

Press Releases
OLIGOMERIX Awarded A Grant For Its Alzheimer’s Drug Discovery Program Targeting Tau Oligomers From The NIH     5/2/2016
Fisher Center for Alzheimer's Research Foundation Scientists Discover Pathway That May Lead To Alzheimer's Disease     4/26/2016
Ortho Kinematics Secures CE Mark Approval To Support International Expansion     4/19/2016
Cantabio Pharmaceuticals Announces The Development Of Small Molecule Chaperones Of The Abeta Peptide For The Treatment Of Alzheimer's Disease In Collaboration With Novalix     4/13/2016
Axovant (AXON) To Present At The Goldman, Sachs & Co. Alzheimer's Symposium     4/5/2016
Probiodrug AG Announces Results Of Chronic Toxicology Studies With PQ912, Its "First In Class" Glutaminyl Cyclase (QC) Inhibitor For The Treatment Of Alzheimer’s Disease     4/4/2016
ORYZON Genomics Announces First Subject Dosed In Phase I Healthy Volunteer Study Evaluating Oral Epigenetic Drug ORY-2001 For Alzheimer's Disease     4/4/2016
Tetra Discovery Partners Advances Alzheimer's Treatment Candidate BPN14770 To Phase I Multiple Ascending Dose Trial     4/1/2016
ProMis Neurosciences Announces Identification Of A Third Novel Therapeutic Target For Alzheimer's Disease     3/18/2016
Accera, Inc. To Present At BIO Asia International Conference     3/14/2016
MedAvante Presents Research On Electronic Clinical Outcome Assessments     3/9/2016
Neurotrope Announces Publication Demonstrating Synaptic Regeneration With The PKC Epsilon Activator Bryostatin, In A Fragile X Disease Late Brain Development Model     3/8/2016
Accera, Inc. Appoints Ernest Wong, Ph.D., As Head Of Corporate Development     3/8/2016
STEM CELLS® Release: Protein-Revved Stem Cell Could Transform Alzheimer's Treatment     3/7/2016
American Academy of Neurology Release: Using A Computer, Social Activities Tied To Reduced Risk Of Memory Decline     3/4/2016